Catamaran Bio is a newly-formed biotechnology company funded by SV Health Investors. Catamaran is developing transformative off-the-shelf CAR-NK cell therapies.

Biotechnology

Health Care

Catamaran Bio

Catamaran Bio's headquarters in Cambridge, MA, United States

Alvin Shih

Caroline G.

Cherry Thomas

Tara Place

Nikola Trbovic

Caroline Gaynor

Catherine Bollard

Branden Moriarity

Maina Bhaman

The Scientific Research Team at Catamaran Bio is responsible for advancing the development of innovative off-the-shelf CAR-NK cell therapies. This team, comprised of experienced directors and scientific founders, focuses on research, experimentation, and clinical translation to enhance therapeutic efficacy and safety. By leveraging their expertise, they aim to transform cancer treatment and drive the company’s scientific vision forward.

Scientific Research Team

The Pharmacology Team at Catamaran Bio focuses on evaluating the efficacy and safety of innovative CAR-NK cell therapies through both in vitro and in vivo studies. This team collaborates closely to design and implement preclinical experiments, analyze pharmacological data, and guide the development of transformative treatments aimed at enhancing patient outcomes in cancer care.

Pharmacology Team

The Leadership Team at Catamaran Bio drives the strategic vision and operational execution of the company, focusing on the development of innovative CAR-NK cell therapies. Composed of experienced leaders from scientific, technical, and human resources backgrounds, this team collaborates to guide research initiatives, oversee manufacturing processes, and foster an organizational culture that supports the company’s growth and mission to revolutionize cancer treatment.

Catamaran Bio

Org chart

Board & advisors

Teams

Scientific Research Team

Pharmacology Team

Leadership Team

Offices

Catamaran Bio

Org chart

Board & advisors

Teams

Scientific Research Team

Pharmacology Team

Leadership Team

Offices

Related companies